Sigma Labs, Inc. | |||||||||
Condensed Statements of Operations | |||||||||
(Unaudited) | |||||||||
Twelve Months Ended | |||||||||
December 31,
2018 |
December 31,
2017 | ||||||||
REVENUES | $ | 388,574 | $ | 641,049 | |||||
COST OF REVENUES | 270,107 | 272,372 | |||||||
GROSS PROFIT (Loss) | 118,467 | 368,677 | |||||||
EXPENSES | |||||||||
Salaries & Benefits | 2,056,584 | 1,509,672 | |||||||
Stock-Based Compensation | 1,145,530 | 719,796 | |||||||
Operating & R&D Costs | 493,410 | 302,043 | |||||||
Investor & Public Relations | 633,035 | 554,990 | |||||||
Legal & Professional Services Fees | 564,854 | 563,300 | |||||||
Office Expense | 466,657 | 324,920 | |||||||
Depreciation & Amortization | 192,374 | 196,943 | |||||||
Other Operating Expenses | 134,827 | 95,989 | |||||||
Total Expenses | 5,687,271 | 4,267,654 | |||||||
OPERATING INCOME (LOSS) | (5,568,804 | ) | (3,898,977 | ) | |||||
OTHER INCOME (EXPENSE) | |||||||||
Interest Income | 35,178 | 40,107 | |||||||
State Incentives | - | 154,568 | |||||||
Change in fair value of derivative liabilities | - | (186,908 | ) | ||||||
Exchange Rate Gain (Loss) | 162 | - | |||||||
Interest Expense | (3,966 | ) | (161,852 | ) | |||||
Loss on Disposal of Assets | (36,733 | ) | (13,161 | ) | |||||
Debt Discount Amortization | - | (358,280 | ) | ||||||
Total Other Income (Loss) | (5,359 | ) | (525,526 | ) | |||||
LOSS BEFORE PROVISION FOR INCOME TAXES | (5,574,163 | ) | (4,424,503 | ) | |||||
Provision for income Taxes | - | - | |||||||
Net Loss | $ | (5,574,163 | ) | $ | (4,424,503 | ) | |||
Preferred Dividends | (15,125 | ) | - | ||||||
Net Loss applicable to Common Stockholders | $ | (5,589,288 | ) | $ | (4,424,503 | ) | |||
Net Loss per Common Share - Basic and Diluted | $ | (0.81 | ) | $ | (1.00 | ) | |||
Weighted Average Number of Shares | |||||||||
Outstanding - Basic and Diluted | 6,898,047 | 4,403,479 | |||||||